New Enterprise Associates 15, L.P.

CIK: 0001629794

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)1 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NEUE

NeueHealth, Inc.

10% Owner

SNTI

Senti Biosciences, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (8 total)

NEUE
NeueHealth, Inc.
Oct 2, 2025
Award(A)
Warrant (Right to Buy)
Direct
434.3K shares-
NEUE
NeueHealth, Inc.
Oct 2, 2025
Sale(S)
Direct
280 shares at avg. $6.75$2K
NEUE
NeueHealth, Inc.
Oct 2, 2025
Exercise(M)
Direct
434.3K shares at avg. $0.01$4K
NEUE
NeueHealth, Inc.
Oct 2, 2025
Tax Payment(F)
Direct
643 shares at avg. $6.75$4K
NEUE
NeueHealth, Inc.
Oct 2, 2025
Disposition(D)
Direct
2M shares-
NEUE
NeueHealth, Inc.
Oct 2, 2025
In-the-Money(X)
Direct
189.2K shares at avg. $0.01$2K
SNTI
Senti Biosciences, Inc.
Mar 10, 2025
Conversion(C)
Direct
3.3M shares-
NEUE
NeueHealth, Inc.
Oct 1, 2024
Purchase(P)
Warrant (Right to Buy)
Direct
61.9K shares-

		Type	Shares	Price		Ownership
Oct 2, 2025	NEUE NeueHealth, Inc.	Award(A) Warrant (Right to Buy)	434,297	-	-	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Sale(S)	280	$6.75	$1,890	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Exercise(M)	434,297	$0.01	$4,343	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Tax Payment(F)	643	$6.75	$4,340	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	Disposition(D)	1,960,591	-	-	Direct
Oct 2, 2025	NEUE NeueHealth, Inc.	In-the-Money(X)	189,195	$0.01	$1,892	Direct
Mar 10, 2025	SNTI Senti Biosciences, Inc.	Conversion(C)	3,333,000	-	-	Direct
Oct 1, 2024	NEUE NeueHealth, Inc.	Purchase(P) Warrant (Right to Buy)	61,865	-	-	Direct

1-8 of 8 transactions

About New Enterprise Associates 15, L.P.

New Enterprise Associates 15, L.P. (SEC CIK 0001629794) files insider reports with the SEC as 10% Owner of NeueHealth, Inc. (NEUE) and 10% Owner of Senti Biosciences, Inc. (SNTI).

Signal8 holds 4 ownership filings by New Enterprise Associates 15, L.P. (1 Form 3, 3 Form 4), filed between Oct 3, 2024 and Oct 6, 2025. Those filings report 8 transactions, from Oct 1, 2024 to Oct 2, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on New Enterprise Associates 15, L.P.'s filings is in TIMONIUM, MD.

Recent filings by New Enterprise Associates 15, L.P.

Oct 2, 2025: Grant or award of NEUE derivative securities (Form 4, code A).
Oct 2, 2025: Open-market sale of NEUE shares (Form 4, code S).
Oct 2, 2025: Option exercise of NEUE shares (Form 4, code M).
Oct 2, 2025: Tax withholding of NEUE shares (Form 4, code F).
Oct 2, 2025: Disposition to issuer transaction of NEUE shares (Form 4, code D).

Other insiders filing for NeueHealth, Inc. (NEUE)

Matushak Jay, Chief Financial Officer
Bessemer Venture Partners IX L.P., 10% Owner
Kraus Stephen, Director
Craig Jeffery Michael, GC & Corporate Secretary
Orozco Tomas, EVP, Consumer Care
Sheehy Robert J, Director

How to read Form 4 transaction codes